Pramipexole is a dopamine agonist primarily used in the treatment of Parkinson’s disease and restless legs syndrome (RLS). It works by stimulating dopamine receptors in the brain, helping improve motor function and reduce symptoms such as tremors, stiffness, and difficulty with movement. In Parkinson’s disease, it can be used alone in early stages or alongside levodopa in advanced cases to reduce “off” periods. For RLS, pramipexole helps relieve uncomfortable sensations in the legs and improves sleep quality. It may also have off‑label uses in certain mood disorders, though such applications require careful medical supervision.